Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,665 | 137,289 | 128,588 | 149,750 | 135,551 |
| Marketable Securities | 255,669 | 243,047 | 344,568 | 261,011 | 232,670 |
| Receivables | 53,976 | 59,717 | 53,837 | 61,518 | 41,123 |
| Inventories | 12,412 | 8,050 | 8,350 | 7,190 | 7,730 |
| Other current assets | 0 | 0 | 0 | 0 | 14,000 |
| TOTAL | $471,602 | $466,978 | $560,846 | $503,367 | $458,636 |
| Non-Current Assets | |||||
| PPE Net | 2,689 | 2,930 | 1,472 | 127 | 195 |
| Investments And Advances | 219,831 | 167,310 | 19,315 | 40,276 | 57,176 |
| Other Non-Current Assets | 146,431 | 147,039 | 132,922 | 112,165 | 105,510 |
| TOTAL | $368,951 | $317,279 | $153,709 | $152,568 | $162,881 |
| Total Assets | $840,553 | $784,257 | $714,555 | $655,935 | $621,517 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,376 | 18,584 | 19,484 | 12,557 | 17,396 |
| Accrued Expenses | 33,868 | 27,736 | 21,972 | 24,825 | 72,958 |
| Other current liabilities | N/A | N/A | N/A | N/A | 14,000 |
| TOTAL | $140,773 | $126,216 | $100,750 | $97,202 | $104,505 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 5,625 | 0 | 0 |
| TOTAL | $20,191 | $19,206 | $17,562 | $10,869 | $10,307 |
| Total Liabilities | $160,964 | $145,422 | $118,312 | $108,071 | $114,812 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,503 | 104,775 | 104,493 | 104,112 | 103,517 |
| Common Shares | 136 | 135 | 134 | 133 | 133 |
| Retained earnings | 543,735 | 512,989 | 465,776 | 430,288 | 402,526 |
| Other shareholders' equity | -390 | 1,394 | 321 | 199 | 531 |
| TOTAL | $679,589 | $638,835 | $596,243 | $547,864 | $506,705 |
| Total Liabilities And Equity | $840,553 | $784,257 | $714,555 | $655,935 | $621,517 |